is crucial for effective management and
prognosis evaluation in this patient population. Early recognition
Begliarzade, Sema,
Sufianov, Albert,
Ilyasova, Tatiana,
Shumadalova, Alina,
Sufianov, Rinat,
Beylerli, Ozal,
Yan, Zhongrui (2024) for early detection, precise
prognosis evaluation, and personalized treatment strategies
Beylerli, Ozal,
Shi, Huaizhang,
Begliarzade, Sema,
Shumadalova, Alina,
Ilyasova, Tatiana,
Sufianov, Albert (2024) avenues for exploration. These ncRNAs exert influence over the
prognosis and treatment resistance of brain
Asadullina, D.D.,
Gilyazova, I.R.,
Ivanova, E.A.,
Izmailova, S.M.,
Gilyazova, G.R.,
Pavlov, V.N.,
Khusnutdinova, E.K. (2024) prognosis and difficult to treat. Despite significant advances in the treatment of ccRCC, immune checkpoint